Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Henry ScheinHSIC +1.11%81 Cash Ratio is 0.04 as of Mar. 2026, which is 20% below its 10-year median of 0.05. GuruFocus rates HSIC with a GF Score™ of 81/100 and a GF Value™ of $84.12 (Fairly Valued). The stock has 9 warning signs investors should review. Among 118 Medical Distribution companies, Henry Schein ranks worse than 88.14% on this metric.
Henry Schein has a Cash Ratio of 0.04. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Henry Schein's Cash Ratio or its related term are showing as below:
HSIC'
s Cash Ratio Range Over the Past 10 Years
Min: 0.02 Med: 0.05 Max: 0.28
Current: 0.04
During the past 13 years, Henry Schein's highest Cash Ratio was 0.28. The lowest was 0.02. And the median was 0.05.
HSIC's Cash Ratio is ranked worse than 88.14% of 118
companies
in the Medical Distribution industry
Industry Median: 0.2
vs HSIC: 0.04
Henry Schein (NAS:HSIC) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Henry Schein Cash Ratio Related Terms
Henry Schein Cash Ratio Historical Data
* Premium members only.
The historical data trend for Henry Schein's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Henry Schein's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henry Schein Cash Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Henry Schein's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Henry Schein's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henry Schein (HSIC) has a Cash Ratio of 0.04 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Henry Schein and its competitors. This is 20% below median its historical median of 0.05. Over the past decade, Henry Schein's Cash Ratio has ranged from 0.02 to 0.28. According to the industry distribution chart, Henry Schein ranks #104 out of 118 companies in the Medical Distribution industry, placing it in the top 88.1%.
Is Henry Schein's Cash Ratio too high?
Henry Schein's current Cash Ratio of 0.04 is 20% below median its 10-year median of 0.05. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 0.28. The Medical Distribution industry median Cash Ratio is 0.20. Henry Schein's value of 0.04 is 80% below this industry median. Based on the distribution chart, Henry Schein ranks #104 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Henry Schein has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's Cash Ratio compare to AHG and ACH?
According to the Medical Distribution industry distribution chart, Henry Schein ranks #104 out of 118 companies for Cash Ratio. This places Henry Schein in the lower half of its industry. The industry median Cash Ratio is 0.20. Henry Schein's value of 0.04 is 80% below this benchmark. Historically, Henry Schein's own Cash Ratio has ranged from 0.02 to 0.28 over the past decade. While the company's 10-year median is 0.05 vs. the industry median of 0.20, Henry Schein has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Distribution company?
The median Cash Ratio among Medical Distribution companies is 0.20, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henry Schein's current Cash Ratio of 0.04 is 80% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Henry Schein and its competitors. For the Medical Distribution industry, the median Cash Ratio is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henry Schein's current Cash Ratio is 0.04, which is 20% below median its own 10-year median of 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (HSIC) is currently considered Fairly Valued. The stock's GF Value™ is $84.12, compared to a current price of $85.47 — trading 1.6% above its estimated fair value. The current Cash Ratio is 0.04, which is 20% below median its 10-year median of 0.05 and 80% below the Medical Distribution industry median of 0.20. Henry Schein's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Henry Schein (HSIC), the current Cash Ratio is 0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henry Schein (HSIC) Overvalued in 2026?
Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued.
The current stock price of $85.47 is trading 1.6% above its estimated GF Value™ of $84.12.
GuruFocus considers Henry Schein to be Fairly Valued.
Key valuation signals for HSIC:
Cash Ratio: 0.04 (20% below median its 10-year median of 0.05)
GF Value™: $84.12 vs. price of $85.47 (1.6% above fair value)
Industry Position: 80% below the Medical Distribution median (#104 of 118)
No single metric tells the full story. See the HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
81GF Score
Get the complete analysis for HSIC
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSIC has been successfully added to your 
